Product image of Mykoderm Mund Zur Anwendung In Der Mundhöhle (Miconazole) supplied by GNH India

Mykoderm Mund Zur Anwendung In Der Mundhöhle

Active Ingredient:
Miconazole
Origin:
EU

Mykoderm Mund Zur Anwendung In Der Mundhöhle (Miconazole)

Miconazole, the active ingredient in Mykoderm Mund Zur Anwendung In Der Mundhöhle, is an imidazole antifungal presented as a topical oral preparation for oromucosal use. It treats oral candidiasis (thrush) by reducing fungal growth in the mouth and oropharynx.
GNH India supplies Mykoderm Mund Zur Anwendung In Der Mundhöhle as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Engelhard Arzneimittel Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Miconazole acts on fungal infections of the oral cavity and related structures.

  • Oral candidiasis (thrush): reduces fungal colonisation and relieves symptoms such as soreness and white plaques.
  • Denture‑associated stomatitis: helps control Candida overgrowth on denture surfaces and surrounding mucosa.
  • Candida‑related mouth lesions: promotes healing of ulcerative lesions caused by fungal infection.

How It Works

  • Miconazole inhibits the fungal enzyme lanosterol 14α‑demethylase, a key step in ergosterol synthesis. By blocking ergosterol production, the drug disrupts fungal cell membrane integrity, leading to increased permeability and ultimately cell death, thereby limiting the growth of Candida species in the oral cavity.

Side Effects

Miconazole may cause local and systemic adverse reactions.

Common Side Effects

  • Altered taste sensation: temporary metallic or bitter taste.
  • Mild burning or stinging: sensation at the application site.
  • Oral irritation: redness or mild discomfort.
  • Nausea: occasional feeling of queasiness.
  • Dry mouth: reduced salivation.
  • Local itching: mild pruritus of the mucosa.

Serious or Rare Side Effects

  • Allergic reactions: rash, swelling, or angioedema.
  • Severe mucosal ulceration: extensive painful lesions.
  • Hepatic enzyme elevation: abnormal liver function tests.
  • Stevens‑Johnson syndrome: rare severe skin reaction.
  • Anaphylaxis: life‑threatening hypersensitivity.
  • Persistent dysgeusia: prolonged taste disturbance.

Precautions & Warnings

Before using Mykoderm Mund, consider the following safety measures.

  • Assess hypersensitivity: avoid if known allergy to miconazole or imidazoles.
  • Evaluate oral health: do not apply to severely damaged or ulcerated mucosa.
  • Review concomitant medications: monitor for interactions with systemic azoles or CYP3A4 substrates.
  • Pregnancy and lactation: consult a healthcare professional before use.
  • Pediatric use: limit to ages and doses prescribed by a clinician.
  • Store at below 25°C: keep in the original pack, protect from moisture and direct sunlight.

Avoid Interactions

Miconazole can affect the pharmacokinetics of several drugs.

Major Interactions (Avoid)

  • Systemic azole antifungals (e.g., ketoconazole, fluconazole): risk of additive toxicity.
  • CYP3A4 substrates with narrow therapeutic index (e.g., certain statins, tacrolimus): increased plasma levels.
  • Warfarin: potentiation of anticoagulant effect, leading to bleeding risk.

Moderate Interactions (Monitor Closely)

  • Oral contraceptives: possible reduction in efficacy, consider backup method.
  • Rifampin or other strong CYP inducers: decreased miconazole exposure.
  • Antacids containing aluminum or magnesium: may alter local drug absorption.

Frequently Asked Questions

Mykoderm Mund Zur Anwendung In Der Mundhöhle is a topical oral preparation containing miconazole that is used to treat fungal infections of the mouth, most commonly oral candidiasis (thrush), as well as denture‑associated stomatitis and other Candida‑related lesions.

Miconazole inhibits the fungal enzyme lanosterol 14α‑demethylase, blocking the synthesis of ergosterol, an essential component of fungal cell membranes. This disruption leads to increased membrane permeability and ultimately fungal cell death, reducing the infection in the oral cavity.

The specific dose and frequency are determined by the prescribing clinician based on the severity of the infection, patient age, and other clinical factors. Patients should follow the healthcare professional’s instructions and not alter the regimen without consultation.

Safety data for miconazole in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using this product.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mykoderm Mund delivers miconazole locally to the oral mucosa, providing high concentrations at the site of infection with minimal systemic exposure. Compared with systemic azoles, it reduces the risk of systemic drug interactions but may be less suitable for extensive esophageal candidiasis, which often requires oral tablets or capsules.

Store the product at temperatures below 25 °C, in its original packaging, protected from moisture and direct sunlight. Keep the container tightly closed when not in use and avoid exposing it to extreme heat or humidity to maintain product stability.

The gel is applied directly to the affected areas of the mouth using a clean fingertip or a disposable applicator, as directed by the prescriber. Patients should spread a thin layer over the lesions and retain it for the recommended contact time before swallowing or rinsing, if instructed.

Serious risks include severe allergic reactions such as angioedema, extensive mucosal ulceration, and rare systemic effects like liver enzyme elevation. Any signs of rash, swelling, difficulty breathing, or persistent ulceration should prompt immediate medical evaluation.

Individuals with a known hypersensitivity to miconazole, other imidazole antifungals, or any component of the formulation should avoid using this product. It is also contraindicated in patients with severely damaged oral mucosa until the underlying condition is treated.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Miconazole

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT